| Document Date: 2013-12-11 22:22:12
Open Document File Size: 70,09 KBShare Result on Facebook
City Pittsburgh / / Company Brooks SA. / Immunobiology Laboratory / / / Event Product Issues / / Facility Massachusetts General Hospital / / IndustryTerm Prevention of diabetes / protein processing / protein processing defect / / MedicalCondition Abo T. Recombinant human tumor necrosis / autoimmune diabetes / advanced disease / end-stage diabetes / insulin-dependent diabetes mellitus / Cancer / full-fledged disease / disease / disease’s / established autoimmune diabetes / stroke / bladder cancer / heart disease / diabetes / end-stage disease / autoimmune disease / human diabetes / rapid recurrent autoimmune disease / immunomodulatory cytokine tumor necrosis factor / AIDS / Lesslauer W. Tumor necrosis / renal failure / long-standing disease / blindness / tuberculosis / I diabetes / / MedicalTreatment immunosuppression / amputations / vaccination / immunotherapy / / OperatingSystem XP / / Organization Harvard Medical School / US Food and Drug Administration / Trans Assoc / Massachusetts General Hospital / / Person DENISE FAUSTMAN / MIRIAM DAVIS / Amer Phys / / Position Director / Associate Professor of Medicine / / Product major histocompatibility complex class / / Technology alpha / transplantation / apoptosis / /
SocialTag |
COVER STORY Immunotherapy for Type 1 Diabetes Takes Aim at Autoreactive T Cells